Drug Shortage Report for CARBOPLATIN INJECTION
Report ID | 135135 |
Drug Identification Number | 02125439 |
Brand name | CARBOPLATIN INJECTION |
Common or Proper name | CARBOPLATIN INJECTION 10MG/ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CARBOPLATIN |
Strength(s) | 10MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 60ml |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-03-03 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-04-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-04-29 | French | Compare |
v3 | 2021-04-29 | English | Compare |
v2 | 2021-03-04 | French | Compare |
v1 | 2021-03-04 | English | Compare |
Showing 1 to 4 of 4